Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-036799)

Filing Details

Accession Number:: 0001209191-21-036799
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-01 16:08:03
Reporting Period:: 2021-05-28

Accepted Time:: 2021-06-01 16:08:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1741830	Kronos Bio Inc.	KRON	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1797819	Marianne Backer De	C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-28	600	$25.01	600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The weighted average purchase price for the transaction reported was $25.01, and the range of prices were between $24.52 and $25.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.